Raymond James Financial’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18M Buy
183,017
+6,397
+4% +$602K ﹤0.01% 1636
2026
Q1
$16.5M Buy
176,620
+18,289
+12% +$1.79M 0.01% 1611
2025
Q4
$15.4M Buy
158,331
+3,466
+2% +$328K ﹤0.01% 1625
2025
Q3
$13.7M Buy
154,865
+1,870
+1% +$162K ﹤0.01% 1684
2025
Q2
$13.2M Sell
152,995
-3,763
-2% -$324K ﹤0.01% 1667
2025
Q1
$14.3M Buy
156,758
+2,257
+1% +$205K 0.01% 1544
2024
Q4
$13.3M Buy
+154,501
New +$14.3M ﹤0.01% 1623

Other funds holding IXJ

Raymond James Financial's IXJ Position: Q2 2026 in Review

Raymond James Financial increased its iShares Global Healthcare ETF (IXJ) stake by 3.6% in Q2 2026, buying an estimated $602K and bringing the position to 183,017 shares worth $18M. The position accounts for ﹤0.01% of the portfolio, ranked #1636.

Raymond James Financial first reported a position in IXJ in Q4 2024 and has held it in 7 quarters since. 301 funds tracked by Wall St. Rank hold IXJ as of Q2 2026.

  • Raymond James Financial held 183,017 shares of iShares Global Healthcare ETF worth $18M as of Q2 2026.
  • Raymond James Financial bought 6,397 iShares Global Healthcare ETF shares in Q2 2026, an estimated $602K.
  • iShares Global Healthcare ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #1636 holding.
  • Raymond James Financial first reported a position in iShares Global Healthcare ETF in Q4 2024 and has held it in 7 quarters since.
  • 301 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.